TENX Latest Press Releases

-- November 1, 2026 --

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX Newsfile 7:34 PM

TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline PRNewswire 2:30 PM

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX Globe Newswire 10:43 AM

-- October 30, 2026 --

TENX Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Tenax Therapeutics, Inc. Class Action Lawsuit Globe Newswire 8:18 PM

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX Newsfile 7:24 PM

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) -- Investors Who Suffered Losses Are Encouraged to Contact the Firm. PRNewswire 12:00 PM

TENX Shareholder Alert: December 28, 2026 Lead Plaintiff Deadline in Tenax Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky ACCESS Newswire 11:50 AM

Lost Money on Tenax Therapeutics, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 89.77% Share Price Drop Business Wire 11:00 AM

ATTENTION NASDAQ: TENX INVESTORS: Contact Berger Montague About a Tenax Therapeutics, Inc. Class Action Lawsuit PRNewswire 9:06 AM

Did You Lose Money on Tenax Therapeutics, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 89.77% Share Price Decline Business Wire 9:00 AM

-- October 29, 2026 --

Kaplan Fox Encourages Tenax Therapeutics, Inc. (TENX) Investors with Significant Losses to Contact the Firm Before December 28, 2026 Newsfile 8:40 PM

TENX INVESTOR DEADLINE: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Business Wire 7:59 PM

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX Globe Newswire 6:10 PM

ROSEN, LEADING INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX Newsfile 5:58 PM

Lost Money on Tenax Therapeutics, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 89.77% Stock Decline Business Wire 3:46 PM

TENX Shareholder Alert: December 28, 2026 Lead Plaintiff Deadline in Tenax Therapeutics, Inc. Securities Class Action - Contact SueWallSt PRNewswire 10:11 AM

Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers - TENX PRNewswire 10:01 AM

-- October 28, 2026 --

TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit PRNewswire 4:15 PM

Rosen Law Firm Urges Tenax Therapeutics, Inc. (NASDAQ: TENX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Business Wire 2:15 PM

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) - Investors Who Suffered Losses Are Encouraged to Contact the Firm Globe Newswire 11:00 AM

Tenax Therapeutics, Inc. (NASDAQ: TENX) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Tenax Therapeutics, Inc. Securities Lawsuit - Contact Portnoy Law Firm Globe Newswire 9:00 AM

-- October 27, 2026 --

TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc. PRNewswire 10:25 PM

TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead the Tenax Therapeutics Class Action Lawsuit - RGRD Law Globe Newswire 6:26 PM

Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers - TENX Globe Newswire 4:34 PM

Kaplan Fox & Kilsheimer LLP Alerts Tenax Therapeutics, Inc. (TENX) Investors to a Securities Class Action Deadline on December 28, 2026 Newsfile 3:00 PM

TENX INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Tenax Therapeutics, Inc. Investors - Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm Globe Newswire 11:42 AM

Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuit Business Wire 12:49 AM

-- September 1, 2026 --

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference Globe Newswire 7:00 AM

-- August 29, 2026 --

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Globe Newswire 8:21 AM

-- August 19, 2026 --

Tenax Therapeutics (TENX) Securities Investigation Notice - Levi & Korsinsky PRNewswire 1:12 PM

-- August 16, 2026 --

TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law Business Wire 5:38 PM

-- August 14, 2026 --

TENX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Tenax Therapeutics (TENX) Business Wire 10:53 AM

-- August 13, 2026 --

TENX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Tenax Therapeutics PRNewswire 12:48 PM

-- August 12, 2026 --

Tenax Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Tenax Therapeutics (TENX) PRNewswire 7:11 PM

-- August 10, 2026 --

Tenax Therapeutics, Inc. (NASDAQ: TENX) Investors: Johnson Fistel Investigates Potential Securities Law Violations After Phase 3 Trial Failure; Shares Plummet Nearly 90% Globe Newswire 9:23 PM

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF Globe Newswire 7:00 AM

-- July 31, 2026 --

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- July 2, 2026 --

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026 Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes